Abstract:
Disclosed is a therapeutic lamp platform hair growth device. According to an exemplary embodiment, disclosed is a phototherapy device comprising a wearable therapeutic lamp platform including a plurality of radiant lamps and a reflective wall disposed to communicate radiant energy from the plurality of radiant lamps to a user treatment area including a scalp of the user, and the wearable lamp platform including a headband operatively associated with supporting the plurality of radiant lamps and reflective wall above the user's scalp.
Abstract:
Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells.
Abstract:
Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells.
Abstract:
A device having medical and veterinary applications of light to antimicrobial and antineoplastic chemicals includes a solution retainer adapted to retain a therapeutic solution against a user, the therapeutic solution including an antimicrobial chemical, an antineoplastic chemical, or both; a fiber optic cable; a light termination on the fiber optic cable that provides light from the fiber optic cable to the therapeutic solution in the solution retainer; and a light source that provides a light of a predetermined wavelength to the fiber optic cable; wherein the light provides a synergistic effect in the therapeutic solution that inhibits microbial or neoplastic growth.
Abstract:
Medical devices with a light source and antimicrobial solution include a solution retainer adapted to retain an antimicrobial solution against a user; a fiber optic cable; a light termination on the fiber optic cable that provides light from the fiber optic cable to the antimicrobial solution in the solution retainer; and a light source that provides a light of a predetermined wavelength to the fiber optic cable. Medical device includes a container, a bowl, a full body suit, garments for body parts, a helmet, and a catheter.
Abstract:
A method for delivering optical stimulation comprises transfecting a target tissue with a light-sensitive channel protein sensitive to light in a wavelength range, delivering light in the wavelength range to the target tissue via an optical stimulation device, substantially simultaneously with delivering light to the target tissue, sensing bioelectric signals, determining a patient therapeutic state based on the bioelectric signals, and adjusting the delivery of the light to the target tissue based on the sensed patient therapeutic state.
Abstract:
A device and method is provided for drug supply. The device comprises a holder suitable for holding a carrier comprising a drug layer (151); a transmission part for transmitting a laser beam from a laser system, via the transmission part to the carrier; a placement provision; arranged for distancing the carrier from the skin or tissue; and a control mechanism. The control mechanism is arranged to moving a laser beam and/or the carrier relative to each other, in order to provide a virginal area of the carrier for the laser beam; and impinging the laser beam via the transmission part on the carrier; in such a way that the carrier is activated to eject a distinct quantity of drug transferred (50) in normal direction from the carrier from the drug layer into the skin or tissue. Accordingly drugs can be injected in a controlled way without using nozzles or needles.
Abstract:
A laser system including: a laser source operable to emit a first and a second laser beam having first and second operating wavelengths, respectively; a fiber optic cable to guide and homogenize the laser beams; an expander to increase the diameter of the laser beams; a cylinder to guide the laser beams and limit respective diameters of the first and second laser beams, wherein the cylinder is positioned after the expander on an optical path of the laser beam; a first optical system to collimate the laser beams, wherein the optical system is positioned after the cylinder on the optical path of the laser beams; a spot-size selector comprising a plurality of apertures, wherein the spot-size selector is positioned after the first optical system on the optical path of the laser beams; and a second optical system to focus the laser beams on a tissue of the patient.
Abstract:
A therapeutic light delivery system is provided that includes one or more fiber optic arrays that channels illumination from an illumination device. An optics module coupled to the one or more fiber optic arrays that provides the illumination to the one or more fiber optic arrays. A control module coupled to the optics module that controls the illumination to the one or more fibers. The illumination comprises a plurality of therapeutic illumination patterns and wavelengths.
Abstract:
A method of using and devices for delivering electromagnetic radiation of a selected wavelength for the treatment of conditions pertaining to cephalic sensory organs, in particular to treating conditions of the eye (ocular conditions) and conditions pertaining to the ear (otic conditions). The invention is in particular for the treatment of organelles associated with the acoustic and optic nerves and more particularly for the treatment of age related degeneration of such organelles. The invention also provides devices for treating ocular and otic conditions.